What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.16%Above 5Y avg (0.72%)
Annual Rate
CNY 0.15Paid annual
Payout Ratio
28.3%Sustainable
Payback Period
87.1 yr
Last Ex-Dividend
May 28, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.56BCNY
982.56M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
23.83x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Revenue (TTM)
2.34BCNY
350.17M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
11.54%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Beta
0.1150x
vs all stocks
Updated Oct 21, 2026
52-Week Change
-20.68%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
6.56BCNY
982.56M · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
7.45BCNY
1.12B · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
23.83x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Forward P/E
18.45x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Price to Sales (TTM)
2.75x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 2.81×.Updated Oct 21, 2026
Price to Book (MRQ)
2.28x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Enterprise to Revenue
3.19x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Enterprise to EBITDA
13.64x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 18.83×.Updated Oct 21, 2026
Gross Margin
43.63%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Profit Margin
11.54%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Operating Margin
17.84%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Return on Assets (TTM)
4.28%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Return on Equity (TTM)
9.65%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Revenue (TTM)
2.34BCNY
350.17M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
4.59CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
9.00%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Gross Profit (TTM)
974.40MCNY
146.05M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
395.53MCNY
59.29M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
269.60MCNY
40.41M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
12.50%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
627.85MCNY
94.11M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
-4.69MCNY
-702.97K · vs all stocks (USD)
Updated Oct 21, 2026
Trailing Annual Dividend Rate
0.1500CNYUpdated Oct 21, 2026
Trailing Annual Dividend Yield
1.16%
vs all stocks
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.72%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
28.30%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Minority Interest (Equity)
257.78MCNYFY2025 · Dec 31, 2025
Revenue
2.25BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.31BCNYFY2025 · Dec 31, 2025
Gross Profit
938.67MCNYFY2025 · Dec 31, 2025
Operating Income
390.55MCNY
58.54M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
320.59MCNYFY2025 · Dec 31, 2025
Income Tax Expense
36.66MCNYFY2025 · Dec 31, 2025
Net Income
283.93MCNYFY2025 · Dec 31, 2025
EBIT
347.11MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
613.01MCNYFY2025 · Dec 31, 2025
Research & Development
174.19MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
117.85MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
29.35MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
7.28MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
26.52MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.5062CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.5062CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
508.58MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
508.58MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
283.93MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-26.49MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
333.08MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-25.73MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
671.67MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
283.93MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
88.02MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-41.38MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
2.51MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-358.81MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
1.29MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-358.52MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.03BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.01BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-101.69MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-327.99MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-412.94MCNYFY2025 · Dec 31, 2025
Shares Outstanding
508.55MSharesUpdated Oct 21, 2026
Float Shares
345.04MSharesUpdated Oct 21, 2026
% Held by Insiders
33.84%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
3.93%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
568.44MCNY
85.20M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
1.12CNYUpdated Oct 21, 2026
Total Debt (MRQ)
1.33BCNY
199.07M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.4303x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Current Ratio (MRQ)
1.68x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
5.55CNYUpdated Oct 21, 2026
Total Assets
5.10BCNY
764.49M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.80BCNYFY2025 · Dec 31, 2025
Total Liabilities
2.08BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
2.30BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
376.87MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.70BCNYFY2025 · Dec 31, 2025
Cash
671.66MCNYFY2025 · Dec 31, 2025
Cash Equivalents
20.39MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
692.05MCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.39BCNYFY2025 · Dec 31, 2025
Inventory
368.74MCNYFY2025 · Dec 31, 2025
Accounts Payable
548.16MCNYFY2025 · Dec 31, 2025
Short-term Debt
807.59MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
7.36MCNYFY2025 · Dec 31, 2025
Long-term Debt
336.35MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
2.03MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
508.55MCNYFY2025 · Dec 31, 2025
Retained Earnings
1.39BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.03BCNY
453.46M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
12.34CNYUpdated Oct 21, 2026
52-Week High
22.96CNYUpdated Oct 21, 2026
52-Week Change
-20.68%
vs all stocks
Updated Oct 21, 2026
Beta
0.1150x
vs all stocks
Updated Oct 21, 2026
50-Day MA
14.13CNYUpdated Oct 21, 2026
200-Day MA
16.81CNYUpdated Oct 21, 2026
Avg 10-Day Volume
8.63MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
8.79MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
0.5300CNYUpdated Oct 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
A weak, thin-volume bounce inside a decline that is still far from recovered.
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Most companies in its industry are production businesses; this one is a rule-setting businessSignificant
Industry peers: 108Share on the common pattern %: 96.00